Review Articles

  1. Research
  2. Review Articles
  3. Review Articles
1
Charan HV, Dwivedi DK, Khan S, Jena GB.. Mechanisms of NLRP3 inflammasome-mediated hepatic stellate cell activation: Therapeutic potential for liver fibrosis. Genes & Diseases 2022, , -.
2
Gupta V, Mohapatra S, Mishra H, Farooq U, Kumar K, Ansari MV, Aldawsari MF, Alalaiwe AS, Mirza MA, Iqbal Z.. Nanotechnology in Cosmetics and Cosmeceuticals?A Review of Latest Advancements. Gels 2022, 8 , 173-.
3
Kaundal RK, Datusalia AK, Sharma SS.. Posttranscriptional regulation of Nrf2 through miRNAs and their role in Alzheimer's disease. Pharmacological Research 2022, 175 (106018), -.
4
Malik JA, Ahmed S, Jan B, Bender O, Al Hagbani T, Alqarni A, Anwar S.. Drugs repurposed: An advanced step towards the treatment of breast cancer and associated challenges. Biomedicine and Pharmacotherapy 2022, 145 (112375), -.
5
Aaghaz S, Sharma K, Jain R, Kamal A.. ß-Carbolines as potential anticancer agents. European Journal of Medicinal Chemistry 2021, 216 (113321), -.
6
Aditya Gupta, Reena Sharma, Kaushik Kuche, Sanyog Jain.. Exploring the Therapeutic Potential of the Bioinspired Reconstituted High Density Lipoprotein Nanostructures. International Journal of Pharmaceutics 2021, 596 (120272), -.
7
Bashir A, Tiwari P and Duseja A.. Enzyme replacement therapy in lysosomal acid lipase deficiency (LAL-D): a systematic literature review. Therapeutic Advances in Rare Disease 2021, 2 , -.
8
Chakraborty S, Chormale JH and Bansal AK.. Deep eutectic systems: An overview of fundamental aspects, current understanding and drug delivery applications. International Journal of Pharmaceutics 2021, 610 (121203), -.
9
Dar MA, Tiwari P, D'Cruz S.. Assessment of Adverse Drug Reactions due to Antimicrobial Drugs in Medicine Inpatients at a Tertiary Care Public Teaching Hospital. International Journal of Medical Science in Clinical Research and Review 2021, 4 , 32-40.
10
Desale K, Kuche K, Jain S.. Cell-penetrating peptides (CPPs): an overview of applications for improving the potential of nanotherapeutics. Biomaterials Science 2021, 9 , 1153-1188.
11
Devi N, Madaan P, Asrar MM, Sahu JK, Bansal D.. Comparative short-term efficacy and safety of add-on anti-seizure medications in Dravet syndrome: An indirect treatment comparison. Seizure 2021, 91 , 316-324.
12
Kathuria D, Raul AD, Wanjari P, Bharatam PV.. Biguanides: Species with versatile therapeutic applications. European Journal of Medicinal Chemistry 2021, 219 (113378), -.
13
Kaur J, Chahal GS, Grover V, Bansal D, Jain A.. Immediate implant placement in periodontally infected sites- A systematic review and meta-analysis. International Academy of Periodontology 2021, 23 , 115-137.
14
Khatun S, Singh A, Bader GN, Sofi FA.. Imidazopyridine, a promising scaffold with potential medicinal applications and structural activity relationship (SAR): recent advances. Journal of Biomolecular Structure and Dynamics 2021, , -..
15
Kirar S, Thakur NS, Reddy YN, Banerjee UC, Bhaumik J, Reddy YN.. Insights on the polypyrrole based nanoformulations for photodynamic therapy. Journal of Porphyrins and Phthalocyanines 2021, 25 , 605-622.
16
Luong A-D, Roy I, Malhotra BD and Luong JHT.. Analytical and biosensing platforms for insulin: A review. Sensors and Actuators Reports 2021, 3 (100028), 100028-.
17
Malavia N, Kuche K, Ghadi R, Jain S.. A bird's eye view of the advanced approaches and strategies for overshadowing triple negative breast cancer. Journal of Controlled Release 2021, 330 , 72-100.
18
Mir RH, Mohi-Ud-din R, Wani TU, Dar MO, Shah AJ, Lone B, Pooja C, Masoodi MH.. Indole: A privileged heterocyclic moiety in the management of cancer. Current Organic Chemistry 2021, 25 , 724-736.
19
Muthusamy R, Bharatam PV.. Molecular modeling studies on cytochrome P450 mediated drug metabolism. Current Drug Metabolism 2021, , -.
20
Parmar PK, Rao SG and Bansal AK.. Co-processing of small molecule excipients with polymers to improve functionality. Expert Opinion on Drug Delivery 2021, 18 , 907-992.
21
Parmar PK, Wadhawan J, Bansal AK.. Pharmaceutical nanocrystals: A promising approach for improved topical drug delivery. Drug Discovery Today 2021, , -.
22
Rashid I, Bashir A, Tiwari P, D?Cruz S, Jaswal S.. Estimates of malnutrition associated with chronic kidney disease patients globally and its contrast with India: An evidence based systematic review and meta-analysis. Clinical Epidemiology and Global Health 2021, 12 (100855), -.
23
Singh R, Joshi V, Mehetre N, Sangamwar AT.. Insights into co-amorphous systems in therapeutic drug delivery. Therapeutic Delivery 2021, 12 , 245-265.
24
Sobhia ME, Kumar GS, Mallick A, Singh H, Kumar K, Chaurasiya M, Singh M, Gera N, Deverakonda S, Baghel V.. Computational and Biological Investigations on Abl1 Tyrosine Kinase: A Review. Current Drug Targets 2021, 22 , 38-51.
25
Verma S, Choudhary RN, Kanadje AP, Banerjee UC.. Diversifying Arena of Drug Synthesis: In the Realm of Lipase Mediated Waves of Biocatalysis. Catalysts 2021, 11 (1328), -.
26
Bhat IA, Kabeer SW, Reza MI, Mir RH, Dar MO.. AdipoRon: A Novel Insulin Sensitizer in Various Complications and the Underlying Mechanisms: A Review. Current Molecular Pharmacology 2020, 13 , 94-107.
27
Chauhan G, Madou MJ, Kalra S, Chopra V, Ghosh D, Chap SOM.. Nanotechnology for COVID-19: Therapeutics and Vaccine Research. ACS Nano 2020, 14 , 7760-7782.
28
Devi N, Boya C, Chhabra M, Bansal D.. N-acetyl-cysteine as adjuvant therapy in female infertility: A systematic review and meta-analysis. Journal of Basic and Clinical Physiology and Pharmacology 2020, , -.
29
Jaladanki CK, Gahlawat A, Rathod G, Sandhu H, Jahan K, Bharatam PV.. Mechanistic studies on the drug metabolism and toxicity originating from cytochromes P450. Drug Metabolism Reviews 2020, 52 , 366-394.
30
Patel D, Zode SS, Bansal AK.. Formulation aspects of intravenous nanosuspensions. International Journal of Pharmaceutics 2020, (119555), -.
31
Sharma S, Mandal A, Kant R, Jachak S, Jagzape M.. Is Cinnamon Efficacious for Glycaemic Control in Type-2 Diabetes Mellitus?. Journal of Pakistan Medical Association 2020, 70 , 2065-2069.
32
Singh IP, Gupta S, Kumar S.. Thiazole Compounds as Antiviral Agents: An Update. Medicinal Chemistry 2020, 16 , 23-4.
33
Singla R, Mishra A, Joshi R, Jha S, Sharma AR, Upadhyay S, Sarma P, Prakash A, Medhi B.. Human animal interface of SARS-CoV-2 (COVID-19) transmission: a critical appraisal of scientific evidence. Veterinary Research Communications 2020, 44 , 119-130.
34
Thakore SD, Sood A, Bansal AK.. Emerging Role of Primary Heterogeneous Nucleation in Pharmaceutical Crystallization. Drug Development Research 2020, 81 , 22-3.
35
Thapak P, Vaidya B, Joshi HC, Singh JN, Sharma SS.. Therapeutic potential of pharmacological agents targeting TRP channels in CNS disorders. Pharmacological Research 2020, 159 (105026), -.
36
Vaidya B, Sharma SS.. Transient Receptor Potential Channels as an Emerging Target for the Treatment of Parkinson's Disease: An Insight Into Role of Pharmacological Interventions. Frontiers in Cell and Developmental Biology 2020, 8 (584513), -.
37
Vishnoi S, Matre H, Garg P, Pandey SK.. Artificial intelligence and machine learning for protein toxicity prediction using proteomics data. Chemical Biology & Drug Design 2020, 96 , 902-920.
38
Aaghaz S, Gohel V, Kamal A.. Peptides as Potential Anticancer Agents. Current Topics in Medicinal Chemistry 2019, 19 , 1491-1511.
39
Adhya P, Sharma SS.. Redox TRPs in diabetes and diabetic complications: mechanisms and pharmacological modulation. Pharmacological Research 2019, 146 (104271), -.
40
Chourasiya SS, Kathuria D, Wani AA, Bharatam PV.. Azines: synthesis, structure, electronic structure and their applications. Organic & Biomolecular Chemistry 2019, 17 , 8486-8521.
41
Iyengar ARS, Pande AH.. Is human Paraoxonase 1 the saviour against the persistent threat of Organophosphorus nerve agents?. Protein & Peptide Letters 2019, 26 , 471-478.
42
Kaur H, Sharma P, Kaur S, Kaur H, Prajapat M, Mahendiratta S, Kumar S, thota P, Prasad D, Medhi B.. Therapeutic options for management of Hori's nevus: A systematic review. Dermatologic Therapy 2019, 33 (e13167), -.
43
Kesharwani SS, Kaur S, Tummala H, Sangamwar AT.. Multifunctional approaches utilizing polymeric micelles to circumvent multidrug resistant tumors. Colloids and Surfaces B: Biointerfaces 2019, 173 , 581-590.
44
Kuche K, Bhargavi N, Dora CP, Jain S.. Drug-Phospholipid Complex?a Go Through Strategy for Enhanced Oral Bioavailability. AAPS PharmSciTech 2019, 20 (43), -.
45
Negi CK, Jena G.. Nrf2, a novel molecular target to reduce type 1 diabetes associated secondary complications: The basic considerations. European Journal of Pharmacology 2019, 843 , 26-12.
46
Raut SY, Manne ASN, Kalthur G, Jain S, Mutalik S.. Cyclodextrins As Carriers In Targeted Delivery Of Therapeutic Agents: Focused Review On Traditional And Inimitable Applications. Current Pharmaceutical Design 2019, 25 , 444-454.
47
Saxena S, Chhibber M, Singh IP.. Fungal bioactive compounds in pharmaceutical research and development. Current Bioactive Compounds 2019, 15 , 211-231.
48
Singh K, Roy I.. Nucleic acid therapeutics in Huntington's disease. Recent Patents on Biotechnology 2019, 13 , 187-206.
49
Sobhia ME, Ghosh K, Singh A, Sul K, Singh M, Kumar R, Sandeep, Merugu S, Donempudi S.. A Multi-perspective Review of Dengue Research. Current Drug Targets 2019, 20 , 1550-1562.
50
Dwivedee BP, Soni S, Sharma M, Bhaumik J, Laha JK, Banerjee UC.. Promiscuity of Lipase-Catalyzed Reactions for Organic Synthesis: A Recent Update. ChemistrySelect 2018, 3 , 2441-2466.
51
Gupta MN, Roy I.. Rear Mirror View of Some Biological Tools and Processes. Proceedings of the Indian National Science Academy 2018, 84 , 611-624.
52
Joshi P, Sangamwar AT.. Stabilizing supersaturated drug-delivery system through mechanism of nucleation and crystal growth inhibition of drugs. Therapeutic Delivery 2018, 9 , 873-885.
53
Kapoor B, Gupta R, Singh SK, Gulati M, Singh S.. Prodrugs, phospholipids and vesicular delivery - An effective triumvirate of pharmacosomes. Advances in Colloid and Interface Science 2018, 253 , 35-65.
54
Kaur N, Narang A, Bansal AK.. Use of biorelevant dissolution and PBPK modeling to predict oral drug absorption. European Journal of Pharmaceutics and Biopharmaceutics 2018, 129 , 222-246.
55
Kumar V, Patel S, Jain R.. New structural classes of antituberculosis agents. Medicinal Research Reviews 2018, 38 , 684-740.
56
Mandal S, Bera T, Dubey G, Saha J, Laha JK.. Uses of K2S2O8 in Metal Catalyzed and Metal Free Oxidative Transformations. ACS Catalysis 2018, 8 , 5085-5144.
57
Prasad S, Roy I.. Converting Enzymes into Tools of Industrial Importance. Recent Patents on Biotechnology 2018, 12 , 33-56.
58
Saini AK, Wal P, Verma M, Chandra S, Singh A, Yadav S, Bansode H, Nischaya K, Saraswat N.. Nebivolol: An appealing, awaited and nitric oxide potentiator drug for the treatment of heart failure. Journal of Young Pharmacists 2018, 10 , 149-154.
59
Sharma K, Aaghaz S, Shenmar K, Jain R.. Short Antimicrobial Peptides. Recent Patents on Anti-Infective Drug Discovery 2018, 13 , 1-12.
60
Singh DK, Sahu A, Kumar S, Singh S.. Critical review on establishment and availability of impurity and degradation product reference standards, challenges faced by the users, recent developments, and trends. TrAC Trends in Analytical Chemistry 2018, 101 , 85-107.
61
Srinivasan K, Sharma SS.. Endocrine pharmacology research in India: Scientific progress in last five years. Proceedings of the Indian National Science Academy 2018, 84 , 73-100.
62
Jena GB, Chavan S.. Implementation of Good Laboratory Practices (GLP) in basic scientific research: Translating the concept beyond regulatory compliance. Regulatory Toxicology and Pharmacology 2017, 89 , 20-25.
63
Patel KA, Sethi R, Dhara AR, Roy I.. Challenges with osmolytes as inhibitors of protein aggregation: Can nucleic acid aptamers provide an answer?. International Journal of Biological Macromolecules 2017, 100 , 75-88.
64
Seth K, Purohit P, Chakraborti AK.. Microwave Assisted Synthesis of Biorelevant Benzazoles. Current Medicinal Chemistry 2017, 24 , 4638-4676.
65
Singh IP, Kumar S, Gupta S.. Naphthyridines with Antiviral Activity - A Review. Medicinal Chemistry 2017, 13 , 430-438.
66
Iyengar AR, Pande AH.. Organophosphate-Hydrolyzing Enzymes as First-Line of Defence Against Nerve Agent-Poisoning: Perspectives and the Road Ahead. The Protein Journal 2016, 35 , 424-439.
67
Khan S, Ahirwar K, Jena G.. Anti-fibrotic effects of valproic acid: role of HDAC inhibition and associated mechanisms. Epigenomics 2016, 8 , 1087-101.
68
Khan S, Bhat ZR, Jena G.. Role of autophagy and histone deacetylases in diabetic nephropathy: Current status and future perspectives. Genes & Diseases 2016, 3 , 211-219.
69
Parikh N, Chakraborti AK.. Phosphodiesterase 4 (PDE4) Inhibitors in the Treatment of COPD: Promising Drug Candidates and Future Directions. Current Medicinal Chemistry 2016, 23 , 129-41.
70
Patel NK, Jaiswal G, Bhutani KK.. A review on biological sources, chemistry and pharmacological activities of pinostrobin. Natural Product Research 2016, 30 , 2017-2027.
71
Bulani Y, Sharma SS.. Therapeutic Potential of Targeting Protease Activated Receptors in Cardiovascular Diseases. Current Pharmaceutical Design 2015, 21 , 4392-4399.
72
Chauhan A and Mittu B.. Soil Health - An Issue of Concern for Environment and Agriculture. Journal of Bioremediation & Biodegradation 2015, 6 (1000286), -.
73
Chauhan A, Mittu B and Chauhan P.. Analytical Method Development and Validation: A Concise Review. Journal of Analytical & Bioanalytical Techniques 2015, 6 (1000233), -.
74
Jadhavar PS, Vaja MD, Dhameliya TM, Chakraborti AK.. Oxazolidinones as Anti-tubercular Agents: Discovery, Development and Future Perspectives. Current Medicinal Chemistry 2015, 22 , 4379-4397.
75
Khan S, Jena G.. The role of butyrate, a histone deacetylase inhibitor in diabetes mellitus: experimental evidence for therapeutic intervention. Epigenomics 2015, 7 , 669-80.
76
Kharatmal SB, Singh JN, Sharma SS.. Voltage-Gated Sodium Channels as Therapeutic Targets for Treatment of Painful Diabetic Neuropathy. Mini Reviews in Medicinal Chemistry 2015, 15 , 1134-1147.
77
Sharma M, Akhtar N, Sambhav K, Shete G, Bansal AK, Sharma SS.. Emerging potential of citrus flavanones as an antioxidant in diabetes and its complications. Current Topics in Medicinal Chemistry 2015, 15 , 187-195.
78
Dara A, Sangamwar AT.. Anticancer patent landscape and technology assessment of Indian public-funded research institutes and organizations. Expert Opinion on Therapeutic Patents 2014, 24 , 893-912.
79
Jain S, Rathod V, Prajapati R, Nandekar PP, Sangamwar AT.. Pregnane X Receptor and P-glycoprotein: a connexion for Alzheimer's disease management. Molecular Diversity 2014, 18 , 895-909.
80
Jain V, Bharatam PV.. Pharmacoinformatic approaches to understand complexation of dendrimeric nanoparticles with drugs. Nanoscale 2014, 6 , 2476-2501.
81
Mishra S, Aeri V, Gaur PK, Jachak SM.. Phytochemical, therapeutic, and ethnopharmacological overview for a traditionally important herb: Boerhavia diffusa Linn. BioMed Research International 2014, 2014 (Article ID 808302), -.
82
Narayanam M, Handa T, Sharma P, Jhajra S, Muthe PK, Dappili PK, Shah RP and Singh S.. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products. Journal of Pharmaceutical and Biomedical Analysis 2014, 87 , 191-217.
83
Sharma M and Garg P.. Computational Approaches for Enzyme Functional Class Prediction: A Review. Current Proteomics 2014, 11 , 17-22.
84
Tarate B, Chavan R, Bansal AK.. Oral solid self-emulsifying formulations: a patent review. Recent Patents on Drug Delivery & Formulation 2014, 8 , 126-143.
85
Arfeen M and Bharatam PV.. Design of Glycogen Synthase Kinase-3 Inhibitors: An Overview on Recent Advancements. Current Pharmaceutical Design 2013, 19 , 4755-4775.
86
Dixit VA and Bharatam PV.. SAR and Computer-Aided Drug Design Approaches in the Discovery of Peroxisome Proliferator-Activated Receptor ? Activators: A Perspective. Journal of Computational Medicine 2013, 2013 (Article ID 406049), -.
87
Kumar A, Negi G and Sharma SS.. Neuroprotection by resveratrol in diabetic neuropathy: concepts & mechanisms. Current Medicinal Chemistry 2013, 20 , 4640-4645.
88
Mahajan S and Singh IP.. Berberine and its derivatives: a patent review (2009 - 2012). Expert Opinion on Therapeutic Patents 2013, 23 , 215-231.
89
Mishra N, Yadav NP, Rai VK, Sinha P, Yadav KS, Jain S, Arora S.. Efficient Hepatic Delivery of Drugs: Novel Strategies and Their Significance. BioMed Research International 2013, 2013 (Article ID 382184), -.
90
Rathod V, Jain S, Nandekar PP and Sangamwar AT.. Human pregnane X receptor: A novel target for anticancer drug development. Drug Discovery Today 2013, 19 , 63-70.
91
Thanki K, Gangwal R, Sangamwar AT and Jain S.. Oral delivery of anticancer drugs: Challenges and opportunities. Journal of Controlled Release 2013, 170 , 15-40.
92
Bansal P and Ajay D.. Laboratory dialysis-past, present and future. Recent Patents on Biotechnology 2012, 6 , 32-44.
93
Ghosh S, Chisti Y and Banerjee UC.. Production of shikimic acid. Biotechnology Advances 2012, 30 , 1425-1431.
94
Jena G, Trivedi PP and Sandala B.. Oxidative stress in ulcerative colitis: an old concept but a new concern. Free Radical Research 2012, 46 , 1339-45.
95
Nandekar PP and Sangamwar AT.. Cytochrome P450 1A1-mediated anticancer drug discovery: in silico findings. Expert Opinion on Drug Discovery 2012, 7 , 771-789.
96
Singh S, Handa T, Narayanam M, Sahu A, Junwal M and Shah RP.. A critical review on the use of modern sophisticated hyphenated tools in the characterization of impurities and degradation products. Journal of Pharmaceutical and Biomedical Analysis 2012, 69 , 148-173.
97
Sobhia ME, Paul S, Shinde R, Potluri M, Gundam V, Kaur A and Haokip T.. Protein tyrosine phosphatase inhibitors: a patent review (2002 - 2011). Expert Opinion on Therapeutic Patents 2012, 22 , 125-153.
98
Agarwal A, Banerjee A and Banerjee UC.. Xanthine oxidoreductase: A journey from purine metabolism to cardiovascular excitation-contraction coupling. Critical Reviews in Biotechnology 2011, 31 , 264-280.
99
Jain AK, Das M, Swarnakar NK and Jain S.. Engineered PLGA nanoparticles: An emerging delivery tool in cancer therapeutics. Critical Reviews in Therapeutic Drug Carrier Systems 2011, 28 , 1-1.
100
Jain JP, Ayen WY and Kumar N.. Self Assembling Polymers as Polymersomes for Drug Delivery. Current Pharmaceutical Design 2011, 17 , 65-79.
101
Negi G, Kumar A, Joshi RP and Sharma SS.. Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: Old perspective with a new angle. Biochemical and Biophysical Research Communications 2011, 408 , 5-1.
102
Prajapati KD, Sharma SS and Roy N.. Current perspectives on potential role of albumin in neuroprotection. Reviews in the Neurosciences 2011, 22 , 355-363.
103
Prasad B, Garg A, Takwani H and Singh S.. Metabolite identification by liquid chromatography-mass spectrometry. TrAC Trends in Analytical Chemistry 2011, 30 , 360-387.
104
Singh IP and Chauthe S.. Small molecule HIV entry inhibitors - Part I: Chemokine receptor antagonists: 2004-2010. Expert Opinion on Therapeutic Patents 2011, 21 , 227-269.
105
Singh IP and Chauthe S.. Small molecule HIV entry inhibitors - Part II: Attachment and fusion inhibitors: 2004-2010. Expert Opinion on Therapeutic Patents 2011, 21 , 399-416.
106
Verma S, Domb AJ and Kumar N.. Nanomaterials for regenerative medicine. Nanomedicine 2011, 6 , 157-181.
107
Bhutani KK and Gohil VM.. Natural products drug discovery research in India: status and appraisal. Indian Journal of Experimental Biology 2010, 48 , 199-207.
108
Chakraborti AK, Garg SK, Kumar R, Motiwala HF and Jadhavar PS.. Progress in COX-2 Inhibitors: A Journey So Far. Current Medicinal Chemistry 2010, 17 , 1563-1593.
109
Kaur K, Jain M, Reddy RP and Jain R.. Quinolines and structurally related heterocycles as antimalarials. European Journal of Medicinal Chemistry 2010, 45 , 3245-3264.
110
Singh IP and Bodiwala HS.. Recent advances in anti-HIV natural products. Natural Product Reports 2010, 27 , 1781-1800.
111
Singh IP, Sidana J, Bharate SB and Foley WJ.. Phloroglucinol compounds of natural origin: Synthetic aspects. Natural Product Reports 2010, 27 , 393-416.
112
Sobhia ME and Singh R.. Rational design of CCR2 antagonists: A survey of computational studies. Expert Opinion on Drug Discovery 2010, 5 , 543-547.
113
Vikram A, Jena GB and Ramarao P.. Insulin-resistance and benign prostatic hyperplasia: The connection. European Journal of Pharmacology 2010, 641 , 75-81.
114
Ayenew Z, Puri V, Kumar L and Bansal AK.. Trends in pharmaceutical taste masking technologies: a patent review. Recent Patents on Drug Delivery & Formulation 2009, 3 , 26-39.
115
Gautam R and Jachak SM.. Recent developments in anti-inflammatory natural products. Medicinal Research Reviews 2009, 29 , 767-820.
116
Jain NK and Roy I.. Effect of trehalose on protein structure. Protein Science 2009, 18 , 24-36.
117
Jain S, Dani P and Sharma RK.. Pharmacoscintigraphy: a blazing trail for the evaluation of new drugs and delivery systems. Critical Reviews in Therapeutic Drug Carrier Systems 2009, 26 , 373-426.
118
Kaur K, Jain M, Kaur T and Jain R.. Antimalarials from nature. Bioorganic & Medicinal Chemistry 2009, 17 , 3229-3256.
119
Khan SA, Rashmi, Hussain MZ, Prasad S and Banerjee UC.. Prospects of biodiesel production from microalgae in India. Renewable and Sustainable Energy Reviews 2009, 13 , 2361-2372.
120
Singh IP, Sidana J, Bansal P and Foley WJ.. Phloroglucinol compounds of therapeutic interest: global patent and technology status. Expert Opinion on Therapeutic Patents 2009, 19 , 847-866.
121
Singh S, Prasad B, Savaliya AA, Shah RP, Gohil VM and Kaur A.. Strategies for characterizing sildenafil, vardenafil, tadalafil and their analogues in herbal dietary supplements, and detecting counterfeit products containing these drugs. TrAC Trends in Analytical Chemistry 2009, 28 , 13-28.
122
Adane L and Bharatam PV.. Modelling and informatics in the analysis of P. falciparum DHFR enzyme inhibitors. Current Medicinal Chemistry 2008, 15 , 1552-1569.
123
Gulati M, Singh S, Chopra D, Duggal S and Kumar R.. Use of liposomal drugs in the treatment of rheumatoid arthritis. Current Rheumatology Reviews 2008, 4 , 63-70.
124
Hiwale P, Amin A, Kumar L and Bansal AK.. Variables affecting reconstitution time of dry powder for injection. Pharmaceutical Technology 2008, 32 , 62-68.
125
Honrao C, Banerjee UC and Bansal P.. IPR and Technological Issues regarding a biopharmaceutical formulation-hemoglobin. Recent Patents on Biotechnology 2008, 2 , 60-67.
126
Jain JP, ChitkaraD, and Kumar N.. Polyanhydrides as localized drug carrier: An update. Expert Opinion on Drug Delivery 2008, 5 , 889-907.
127
Jain JP, Sokolsky M, Kumar N and Domb AJ.. Fatty acid based biodegradable polymers. Polymer Reviews 2008, 48 , 156-191.
128
Kaur G and Roy I.. Therapeutic applications of aptamers. Expert Opinion on Investigational Drugs 2008, 17 , 43-60.
129
Kumar L, Amin A and Bansal AK.. Salt selection in drug development. Pharmaceutical Technology 2008, 32 , 128-146.
130
Kumar V, Prasad B and Singh S.. Pharmaceutical issues in the development of a polypill for the treatment of cardiovascular diseases. Drug Discovery Today: Therapeutic Strategies 2008, 5 , 63-71.
131
Malik R and Roy I.. Design and development of antisense drugs. Expert Opinion on Drug Discovery 2008, 3 , 1189-1207.
132
Mohan CG and Gandhi T.. Therapeutic potential of voltage gated calcium channels. Mini Reviews in Medicinal Chemistry 2008, 8 , 1285-1290.
133
Monga V, Meena CL, Kaur N and Jain R.. Chemistry and biology of thyrotropin-releasing hormone (TRH) and its analogs. Current Medicinal Chemistry 2008, 15 , 2718-2733.
134
Saklani A and Kutty SK.. Plant-derived compounds in clinical trials. Drug Discovery Today 2008, 13 , 161-171.
135
Bansal SS, Joshi A and Bansal AK.. New dosage formulations for targeted delivery of cyclo-oxygenase-2 inhibitors: Focus on use in the elderly. Drugs and Aging 2007, 24 , 441-451.
136
Bharatam PV, Patel DS, Adane L, Mittal A and Sundriyal S.. Modeling and informatics in the design of anti diabetic agents. Current Pharmaceutical Design 2007, 13 , 3518-3530.
137
Bhutani KK, Birari R and Kapat K.. Potential anti-obesity and lipid lowering natural products: a review. Natural Product Communications 2007, 2 , 331-348.
138
Birari RB and Bhutani KK.. Pancreatic lipase inhibitors from natural sources: Unexplored potential. Drug Discovery Today 2007, 12 , 879-889.
139
Gautam R, Saklani A and Jachak SM.. Indian medicinal plants as a source of antimycobacterial agents. Journal of Ethnopharmacology 2007, 110 , 200-234.
140
Jachak SM.. PGE synthase inhibitors as an alternative to COX-2 inhibitors. Current Opinion in Investigational Drugs 2007, 8 , 411-415.
141
Jachak SM and Saklani A.. Challenges and opportunities in drug discovery from plants. Current Science 2007, 92 , 1251-1257.
142
Kadam RU and Roy N.. Recent trends in drug-likeness prediction: A comprehensive review of in silico methods. Indian Journal of Pharmaceutical Sciences 2007, 69 , 609-615.
143
Kumar L, Amin A and Bansal AK.. An overview of automated systems relevant in pharmaceutical salt screening. Drug Discovery Today 2007, 12 , 1046-1053.
144
Mital A.. Recent advances in antimalarial compounds and their patents. Current Medicinal Chemistry 2007, 14 , 759-773.
145
Mohan CG, Gandhi T, Garg D, and Shinde R.. Computer assisted methods in chemical toxicity prediction. Mini Reviews in Medicinal Chemistry 2007, 7 , 499-507.
146
Patel DS, Dessaalew, Iqbal P and Bharatam PV.. Structure-based approaches in the design of GSK-3 selective inhibitors. Current Protein and Peptide Science 2007, 8 , 352-364.
147
Roy I, Mondal K and Gupta MN.. Leveraging protein purification strategies in proteomics. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences 2007, 849 , 32-42.
148
Amin A and Bansal AK.. Formulation development for sterile liquid products in blow-fill-seal packs. Pharmaceutical Technology 2006, 30 , 142-154.
149
Chitkara D, Shikanov A, Kumar N and Domb AJ.. Biodegradable Injectable In Situ Depot Forming Drug Delivery Systems. Macromolecular Biosciences 2006, 6 , 977-990.
150
Italia JL, Bhardwaj V and Ravi Kumar MNV.. Disease, destination, dose and delivery aspects of ciclosporin: the state of the art. Drug Discovery Today 2006, 11 , 846-854.
151
Jachak SM.. Cyclooxygenase inhibitory natural products: current status. Current Medicinal Chemistry 2006, 13 , 659-678.
152
Modi S, Prakash Jain J, Domb AJ and Kumar N.. Exploiting EPR in polymer drug conjugate delivery for tumor targeting. Current Pharmaceutical Design 2006, 12 , 4785-4796.
153
Patel S, Kaushal AM and Bansal AK.. Compression physics in the formulation development of tablets. Critical Reviews in Therapeutic Drug Carrier Systems 2006, 23 , 1-1.
154
Paul AT, Gohil VM and Bhutani KK.. Modulating TNF-alpha signaling with natural products. Drug Discovery Today 2006, 11 , 725-732.
155
Ramachandran U, Kumar R and Mittal A.. Fine tuning of PPAR ligands for type 2 diabetes and metabolic syndrome. Mini Reviews in Medicinal Chemistry 2006, 6 , 563-573.
156
Ratnam DV, Ankola DD, Bhardwaj V, Sahana DK and Ravi Kumar MNV.. Role of antioxidants in prophylaxis and therapy: A pharmaceutical perspective. Journal of Controlled Release 2006, 113 , 189-207.
157
Shah B, Kakumanu VK and Bansal AK.. Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids. Journal of Pharmaceutical Sciences 2006, 95 , 1641-1665.
158
Sharma G, Anabousi S, Ehrhardt C and Ravi Kumar MNV.. Liposomes as targeted drug delivery systems in the treatment of breast cancer. Journal of Drug Targeting 2006, 14 , 301-310.
159
Singh IP and Bharate SB.. Phloroglucinol compounds of natural origin. Natural Product Reports 2006, 23 , 558-591.
160
Singh PP.. Malaria and macrophages: Cellular and molecular basis of pathogenesis and immune protection. Journal of Parasitic Diseases 2006, 30 , 116-124.
161
Singh S and Kumar V.. Recent developments on long-term stability test conditions. The Pharma Review 2006, 5 , 61-68.
162
Sundriyal S, Sharma RK and Jain R.. Current advances in antifungal targets and drug development. Current Medicinal Chemistry 2006, 13 , 1321-1335.
163
Tripathy CB and Roy N.. Meta-analysis of glutathione S-transferase M1 genotype and risk toward head and neck cancer. Head Neck 2006, 28 , 217-224.
164
Vangapandu S, Jain M, Kaur K, Patil P, Patel SR and Jain R.. Recent advances in antimalarial drug development. Medicinal Research Reviews 2006, 27 , 65-107.
165
Varma MV, Perumal OP, Panchagnula R.. Functional role of P-glycoprotein in limiting peroral drug absorption: optimizing drug delivery. Current opinion in chemical biology 2006, 10 , 367-373.
166
Arun KHS and Ramarao P.. Saga of Renin-Angiotensin System and Calcium Channels in Hypertensive Diabetics: Does it Have a Therapeutic Edge?. Cardiovascular Drug Reviews 2005, 23 , 99-114.
167
Arun KHS, Kaul CL and Ramarao P.. Green fluorescent proteins in receptor research: an emerging tool for drug discovery. Journal of Pharmacological and Toxicological Methods 2005, 51 , 23-1.
168
Bansal AK and Koradia V.. The role of reverse engineering in the development of generic formulations. Pharmaceutical Technology 2005, 29 , 50-55.
169
Gandhi R, Ashokraj Y, Kaul CL and Panchagnula R.. Using extrusion-spheronization to develop: Controlled-release formulations of azithromycin. Pharmaceutical Technology 2005, 29 , 68-86.
170
Jain JP, Modi S, Domb AJ and Kumar N.. Role of polyanhydrides as localized drug carriers. Journal of Controlled Release 2005, 103 , 541-563.
171
Jain R and Chawrai S.. Advancements in the anti-diabetes chemotherapeutics based on amino acids, peptides, and peptidomimetics. Mini Reviews in Medicinal Chemistry 2005, 5 , 469-477.
172
Jena GB, Kaul CL and Ramarao P.. Regulatory requirements and ICH guidelines on carcinogenicity testing of pharmaceuticals: A review on current status. Indian Journal of Pharmacology 2005, 37 , 209-222.
173
Kashyap N, Kumar N and Ravi Kumar MNV.. Hydrogels for pharmaceutical and biomedical applications. Critical Reviews in Therapeutic Drug Carrier Systems 2005, 22 , 107-150.
174
Kumar N, Bentolila A and Domb AJ.. Structure and biological activity of heparinoid. Mini Reviews in Medicinal Chemistry 2005, 5 , 441-447.
175
Nayyar A and Jain R.. Recent advances in new structural classes of anti-tuberculosis agents. Current Medicinal Chemistry 2005, 12 , 1873-1886.
176
Rai HS, Bansal TK, Bhattacharyya MS, Banerjee UC, Singh J and Vats P.. Removal of dyes from the effluent of textile and dyestuff manufacturing industry: A review of emerging techniques with reference to biological treatment. Critical Reviews in Environmental Science and Technology 2005, 35 , 219-238.
177
Singh IP, Bharate SB and Bhutani KK.. Anti-HIV natural products. Current Science 2005, 89 , 269-290.
178
Singh IP, Bharate SB and Bhutani KK.. Interaction of herbs and food products with drugs: Grape fruit juice as an example. Natural Product Radiance 2005, 4 , 107-112.
179
Singh M, Singh S, Dubey S, Soni P and Banerjee UC.. Influence of process parameters on the production of metabolites in solid-state fermentation. Malaysian Journal of Microbiology 2005, 1 , 9-1.
180
Singh S, Kate BN and Banerjee UC.. Bioactive compounds from cyanobacteria and microalgae: an overview. Critical Reviews in Biotechnology 2005, 25 , 73-95.
181
Sonkusare SK, Kaul CL and Ramarao P.. Dementia of Alzheimer's disease and other neurodegenerative disorders?memantine, a new hope. Pharmacological Research 2005, 51 , 17-1.
182
Vats P, Bhattacharyya MS and Banerjee UC.. Use of phytases (myo-inositolhexakisphosphate phosphohydrolases) for combatting environmental pollution: A biological approach. Critical Reviews in Environmental Science and Technology 2005, 35 , 469-486.
183
Vats RK, Kumar V, Kothari A, Mital A and Ramachandran U.. Emerging targets for diabetes. Current Science 2005, 88 , 241-249.
184
Bala I, Hariharan S and Ravi Kumar MNV.. PLGA Nanoparticles in Drug Delivery: The State of the Art. Critical Reviews in Therapeutic Drug Carrier Systems 2004, 21 , 387-422.
185
Banerjee A, Chisti Y and Banerjee UC.. Streptokinase-a clinically useful thrombolytic agent. Biotechnology Advances 2004, 22 , 287-307.
186
Kalia V, Jadhav AN and Bhutani KK.. Luteinizing hormone estimation. Endocrine Research 2004, 30 , 17-1.
187
Kaushal AM, Gupta P and Bansal AK.. Amorphous drug delivery systems: Molecular aspects, design and performance. Critical Reviews in Therapeutic Drug Carrier Systems 2004, 21 , 133-193.
188
Nachaegari SK and Bansal AK.. Coprocessed excipients for solid dosage forms. Pharmaceutical Technology (North America) 2004, 28 , 52-64.
189
Panchagnula R and Agrawal S.. Biopharmaceutic and pharmacokinetic aspects of variable bioavailability of Rifampicin. International Journal of Pharmaceutics 2004, 271 , 4-1.
190
Panchagnula R, Agrawal S, Ashokraj Y, Varma M, Khandavilli S, Bhardwaj V, Bedi S, Gulati I, Parmar J, Kaul CL, Blomberg B, Fourie B, Roscigno G, Wire R, Laing R, Evans P and Moore T.. Fixed dose combinations for tuberculosis: Lessons learned from clinical, formulation and regulatory perspective. Methods and Findings in Experimental and Clinical Pharmacology 2004, 26 , 703-721.
191
Ramachandran U and Sharma M.. . The Pharma Review 2004, 2 , 19-27.
192
Ravi Kumar MNV, Hellerman G, Lockey RF and Mohapatra SS.. Nanoparticle-mediated gene delivery: the state of the art. Expert Opinion on Biological Therapy 2004, 4 , 1213-1224.
193
Ravi Kumar MNV, Muzzarelli RA, Muzzarelli C, Sashiwa H and Domb AJ.. Chitosan chemistry and pharmaceutical perspectives. Chemical Reviews 2004, 104 , 6017-6084.
194
Tamilvanan S.. Oil-in-water lipid emulsions: implications for parenteral and ocular delivering systems. Progress in Lipid Research 2004, 43 , 489-533.
195
Tamilvanan S and Benita S.. The potential of lipid emulsion for ocular delivery of lipophilic drugs. European Journal of Pharmaceutics and Biopharmaceutics 2004, 58 , 357-368.
196
Varma MVS, Khandavilli S, Ashokraj Y, Jain A, Dhanikula A, Sood A, Narisetty ST, Pillai O, Sharma P, Gandhi R, Agrawal S, Nair VB and Panchagnula R.. Biopharmaceutic classification system: A scientific framework for pharmacokinetic optimization in drug research. Current Drug Metabolism 2004, 5 , 375-388.
197
Vats P and Banerjee UC.. Production studies and catalytic properties of phytases (myo-inositolhexakisphosphate phosphohydrolases): an overview. Enzyme and Microbial Technology 2004, 35 , 14-3.
198
Verma NK and Dey CS.. RNA Mediated gene silencing: mechanisms and its therapeutic applications. Journal of Clinical Pharmacy and Therapeutics 2004, 29 , 395-404.
199
Verma RK, Arora S and Garg S.. Osmotic pumps in drug delivery. Critical Reviews in Therapeutic Drug Carrier Systems 2004, 21 , 477-520.
200
Bhutani KK.. Herbal medicines- an enigma and challenge to science and directions for future initiatives. Indian Journal of Natural Product 2003, 19 , 10-3.
201
Chawla G, Gupta P, Koradia V and Bansal AK.. Gastroretention - a means to address regional variability in intestinal drug absorption. Pharmaceutical Technology (North America) 2003, 27 , 50-68.
202
Garg S, Raghupathi K, Vermani K, Tambwekar KR, Garg A, Waller DP and Zaneveld LJD.. Development Pharmaceutics of Microbicide Formulations Part I: Preformulation Considerations and Challenges. AIDS Patient Care and STDs 2003, 17 , 17-32.
203
Garg S, Tambwekar KR, Vermani K, Raghupathi K, Garg A, Waller DP and Zaneveld LJD.. Development Pharmaceutics of Microbicide Formulations Part II: Formulation, Evaluation, and Challenges. AIDS Patient Care and STDs 2003, 17 , 377-399.
204
Singal P and Singh PP.. Cellular and cytokine responses in Leishmaniasis. Journal of Parasitic Diseases 2003, 27 , 12-1.
205
Tambwekar KR, Madhuri V, Kakaria RB, Garg S.. An Update On Pharmacotherapies Of Smoking Cessation. Indian Journal of Pharmaceutical Sciences 2003, 65 , 450-460.
206
Vasir JK, Tambwekar K and Garg S.. Bioadhesive microspheres as a controlled drug delivery system. International Journal of Pharmaceutics 2003, 255 , 13-32.
207
Verma MVS, Ashokrai Y, Dey, CS and Panchagnula R.. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacological Research 2003, 48 , 347-359.
208
Arora P, Sharma S and Garg S.. Permeability issues in nasal drug delivery. Drug Discovery Today 2002, 7 , 967-975.
209
Bakshi M and Singh S.. Development of validated stability-indicating assay methods?critical review. Journal of Pharmaceutical and Biomedical Analysis 2002, 28 , 1011-1040.
210
Banerjee A, Sharma R, Chisti Y and Banerjee UC.. Botryococcus braunii: a renewable source of hydrocarbons and other chemicals. Critical Reviews in Biotechnology 2002, 22 , 245-279.
211
Bansal AK.. Product development issues of powders for injection. Pharmaceutical Technology 2002, 26 , 122-132.
212
Gupta P, Vermani K and Garg S.. Hydrogels: from controlled release to pH-responsive drug delivery. Drug Discovery Today 2002, 7 , 569-579.
213
Jayanarayan KG and Dey CS.. Microtubules: Dynamics, drug interaction and drug resistance in Leishmania. Journal of Clinical Pharmacy and Therapeutics 2002, 27 , 313-320.
214
Singh S, Rao KVR, Venugopal K and Manikandan R.. Alteration in dissolution characteristics of gelatin-containing formulations: a review of the problem, test methods, and solutions. Pharmaceutical Technology 2002, 26 , 36-58.
215
Thiyagarajan M.. α-Adrenoceptor antagonists in the treatment of benign prostate hyperplasia. Pharmacology 2002, 65 , 119-128.
216
Verma RK, Krishna DM and Garg S.. Formulation aspects in the development of osmotically controlled oral drug delivery systems. Journal of Controlled Release 2002, 79 , 27-7.
217
Vermani K and Garg S.. Herbal medicines for sexually transmitted diseases and AIDS. Journal of Ethnopharmacology 2002, 80 , 49-66.
218
Agrawal S, Thomas NS, Dhanikula AB, Kaul CL and Panchagnula R.. Antituberculosis drugs and new drug development. Current Opinion in Pulmonary Medicine 2001, 7 , 142-147.
219
Garg A, Garg S, Zaneveld L and Singla A.. An update on the chemistry and pharmacology of the citrus bioflavanoid-hesperidin. Phytotherapy Research 2001, 15 , 655-669.
220
Kaul CL and Ramarao P.. The role of aldose reductase inhibitors in diabetic complications: recent trends. Methods and Findings in Experimental and Clinical Pharmacology 2001, 23 , 465-475.
221
Panchagnula R, Agrawal S and Kaul CL.. Fixed dose combinations in treatment of tuberculosis. Indian Journal of Pharmaceutical Sciences 2001, 63 , 9-1.
222
Pillai O and Panchagnula R.. Polymers in drug delivery. Current Opinion in Chemical Biology 2001, 5 , 447-451.
223
Pillai O, Dhanikula AB and Panchagnula R.. Drug delivery: an odyssey of 100 years. Current Opinion in Chemical Biology 2001, 5 , 439-446.
224
Pillai O, Nair V, Jain AK, Thomas NS and Panchagnula R.. Noninvasive transdermal delivery of peptides and proteins. Drugs of the future 2001, 26 , 779-791.
225
Singh S, Mariappan TT, Shankar R, Sharda N and Singh B.. A critical review of the probable reasons for the poor variable bioavailability of rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem. International Journal of Pharmaceutics 2001, 228 , 17-5.
226
Sood A and Panchagnula R.. Peroral route: an opportunity for protein and peptide drug delivery. Chemical Reviews 2001, 101 , 3275-3303.
227
Geetha T and Singh S.. Applications of immobilized stationary-phase liquid chromatography: a potential in vitro technique. Pharmaceutical Science & Technology Today 2000, 3 , 406-416.
228
Grover M, Singh B, Bakshi M and Singh S.. Quantitative structure-property relationships in pharmaceutical research - Part 1. Pharmaceutical Science & Technology Today 2000, 3 , 28-35.
229
Grover M, Singh B, Bakshi M and Singh S.. Quantitative structure-property relationships in pharmaceutical research - Part 2. Pharmaceutical Science & Technology Today 2000, 3 , 50-57.
230
Jain AK and Panchagnula R.. Skeletal drug delivery systems. International Journal of Pharmaceutics 2000, 206 , 12-1.
231
Panchagnula R and Thomas NS.. Biopharmaceutics and pharmacokinetics in drug research. International Journal of Pharmaceutics 2000, 201 , 131-150.
232
Panchagnula R, Jain AK, Pillai O and Jaiswal J.. Nicotine transdermal systems: pharmaceutical and clinical aspects. Methods and Findings in Experimental and Clinical Pharmacology 2000, 22 , 299-308.
233
Panchagnula R, Pillai O, Nair VB and Ramarao P.. Transdermal Iontophoresis revisited. Current Opinion in Chemical Biology 2000, 4 , 468-473.
234
Singh S and Bakshi M.. Guidance on conduct of stress tests to determine inherent stability of drugs. Pharmaceutical Technology Asia 2000, Sep , 24-36.
235
Dhanikula AB and Panchagnula R.. Localized paclitaxel delivery. International Journal of Pharmaceutics 1999, 183 , 85-100.
236
Nair V, Pillai O, Ramarao P and Panchagnula R.. Transdermal Iontophoresis. Part I: Basic Principles and Considerations. Methods and Findings in Experimental and Clinical Pharmacology 1999, 21 , 139-151.
237
Pillai O, Nair V, Ramarao P and Panchagnula R.. Transdermal Iontophoresis. Part II: Peptide and Protein Delivery. Methods and Findings in Experimental and Clinical Pharmacology 1999, 21 , 229-240.
238
Sharma P, Chawla HPS and Panchagnula R.. The role of sorption promoters in increasing the bioavailability of drugs in oral preparations. Drugs of the future 1999, 24 , 1221-1240.
239
Gulati M, Bajaj S, Singh S, Ferdous AJ and Singh M.. Development of liposomal amphotericin formulation. Journal of Microencapsulation 1998, 15 , 137-151.
240
Gulati M, Grover M, Singh S and Singh M.. Lipophilic drug derivatives in liposomes. International Journal of Pharmaceutics 1998, 165 , 129-168.
241
Panchagnula R.. Pharmaceutical aspects of paclitaxel. International Journal of Pharmaceutics 1998, 172 , 15-1.
242
Panchagnula R.. Transdermal delivery of drugs. Indian Journal of Pharmacology 1997, 29 , 140-156.
243
Panchagnula R and Dey CS.. Monoclonal antibodies in drug targeting. Journal of Clinical Pharmacy and Therapeutics 1997, 22 , 19-7.

Information: Duration to be uploaded/incorporated on archival site after the completion of process is 12 months.

243|1|0